...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Cancer: A Journal of the American Cancer Society >Metrics for evaluating patient navigation during cancer diagnosis and treatment : Crafting a policy-relevant research agenda for patient navigation in cancer care.
【24h】

Metrics for evaluating patient navigation during cancer diagnosis and treatment : Crafting a policy-relevant research agenda for patient navigation in cancer care.

机译：用于评估癌症诊断和治疗期间患者导航的指标：制作癌症护理中患者导航的政策相关研究议程。

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

BACKGROUND: Racial and ethnic minorities as well as other vulnerable populations experience disparate cancer-related health outcomes. Patient navigation is an emerging health care delivery innovation that offers promise in improving quality of cancer care delivery to these patients who experience unique health-access barriers. Metrics are needed to evaluate whether patient navigation can improve quality of care delivery, health outcomes, and overall value in health care during diagnosis and treatment of cancer. METHODS: Information regarding the current state of the science examining patient navigation interventions was gathered via search of the published scientific literature. A focus group of providers, patient navigators, and health-policy experts was convened as part of the Patient Navigation Leadership Summit sponsored by the American Cancer Society. Key metrics were identified for assessing the efficacy of patient navigation in cancer diagnosis and treatment. RESULTS: Patient navigation data exist for all stages of cancer care; however, the literature is more robust for its implementation during prevention, screening, and early diagnostic workup of cancer. Relatively fewer data are reported for outcomes and efficacy of patient navigation during cancer treatment. Metrics are proposed for a policy-relevant research agenda to evaluate the efficacy of patient navigation in cancer diagnosis and treatment. CONCLUSIONS: Patient navigation is understudied with respect to its use in cancer diagnosis and treatment. Core metrics are defined to evaluate its efficacy in improving outcomes and mitigating health-access barriers. Cancer 2011;117(15 suppl):3563-572. (c) 2011 American Cancer Society.
机译：背景：种族和少数群体以及其他弱势群体的群体经历差异癌症相关的健康结果。患者导航是一种新兴的医疗保健送货创新，提供了提高癌症护理质量的承诺，这些患者对这些体验独特的健康访问障碍的患者。需要度量来评估患者导航是否可以提高护理递送质量，健康结果和癌症期间医疗保健的总价值。方法：通过搜索公布的科学文献，收集了关于患者导航干预措施的当前国家的信息。作为美国癌症协会赞助的患者导航领导峰会的​​一部分，召开了一部分提供者，患者导航员和健康政策专家。确定了评估患者导航在癌症诊断和治疗中的疗效的关键指标。结果：癌症护理的所有阶段都存在患者导航数据;然而，在预防，筛选和早期癌症诊断过程中，文献对其实施更加强大。据报道，患者导航期间癌症治疗期间的结果相对较少。提出了对政策相关的研究议程的指标，以评估患者导航在癌症诊断和治疗中的疗效。结论：对癌症诊断和治疗的使用，将患者导航被解读。核心指标被定义为评估其在改善结果和减轻健康访问障碍方面的疗效。癌症2011; 117（15个）：3563-572。 （c）2011年美国癌症协会。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号